Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
-
Narrated by:
-
By:
About this listen
Did you know that the prevalence of acquired ESR1 mutations increases after exposure to endocrine therapy?
Credit available for this activity expires: 11/26/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-copd-care-through-precision-medicine-and-patient-2025a1000x00?ecd=bdc_podcast_libsyn_mscpedu
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.